Post-earnings recap
Reported
Wed, Feb 25, 2026
EPS actual
$0.07
EPS est.
$0.03
EPS surprise
+169.23%
1-day move
+21.37%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
The strong EPS performance, significantly above expectations, led to a notable stock increase of 21.37%. Investors reacted positively to the company's ability to manage costs effectively. However, the lack of revenue data and guidance leaves some uncertainty about future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.07 | N/A | +169.23% |
| Revenue | N/A | N/A | N/A |
Management expressed satisfaction with the EPS results, highlighting effective cost management. They emphasized their commitment to enhancing patient care.
We are pleased with our performance this quarter, particularly in managing costs.
Our focus remains on improving patient care and operational efficiency.